Physical and Engineering Sciences in Oncology
Page 2

a) The development of novel non-traditional physical and engineering sciences based approaches, materials, or platforms to thoroughly comprehend cancer disorders.

b) The generation of unique sets of physical measurements that are capable of providing insight into molecular mechanisms of oncogenesis, metastasis, drug resistance or other aspects of cancer that could potentially lead to a more effective treatment of the disease.

c) The development and evaluation of theoretical approaches that would provide a comprehensive and dynamic understanding of cancer disorders.

The NSF estimates that it would award 5 to 10 grants to different applicants, with each grant amounting to $2,000,000 to $3,000,000.

The institutions and organizations that will be considered eligible to submit an application for the Physical and Engineering Sciences in Oncology Program are the following:

a) Universities and two- and four-year colleges including community colleges that are located in the United States

b) Non-profit, non-academic organizations such as Independent museums, observatories, research laboratories and professional societies

c) For-profit organizations

d) State, Local, City and Township Governments

e) Unaffiliated Individuals such as Scientists, engineers or educators

f) Foreign organizations

g) Other Federal agencies.


Physical and Engineering Sciences in Oncology
  Back to Page 1

About The Author Michael Saunders is an editor of TopGovernmentGrants.com one the the most comprehensive Websites offering information on government grants and federal government programs. He also maintains Websites providing resources on community grants and health grants.

Additional Resources

category - Health Grants

The Collaborative Islet Transplantation Registry Program
The National Institutes of Health has formed a partnership with the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) in order to establish the The Collaborative Islet Transplantation Registry Program wherein both agencies seek to invite applications that intend to continue initiatives started through the Collaborative Islet Transplantation Registry (CITR).

---

Minor Use Minor Species Development of Drugs: Research Project Grant
The National Institutes of Health has partnered with the U.S. Food and Drug Administration (FDA) and the Center for Veterinary Medicine(CVM) in an effort to establish the Minor Use Minor Species Development of Drugs: Research Project Grant.

---

Small Business Innovation Research Phase IIB Bridge Awards
In line with this mission, the NIH has recently constituted the Small Business Innovation Research Phase IIB Bridge Awards to Accelerate the Development of Cancer Therapeutics, Imaging Technologies, Interventional Devices, Diagnostics, and Prognostics Toward Commercialization Program.

---

Early-Stage Innovative Technology Development for Cancer Research Program
The National Institutes of Health has collaborated with the National Cancer Institute(NCI) in order to establish Early-Stage Innovative Technology Development for Cancer Research Program, wherein both agencies intend to solicit grant applications expressing intents to conduct funded exploratory research projects that concentrate on the inception and development unique, innovative technological advances that could potentially be utilized in the study of cancer.

---